| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |